Lenacapavir Sodium is a first-in-class HIV-1 capsid inhibitor indicated for the treatment and prevention of HIV-1 infection, functioning by targeting the viral capsid protein to disrupt multiple stages… Read more
Lenacapavir Sodium is a first-in-class HIV-1 capsid inhibitor indicated for the treatment and prevention of HIV-1 infection, functioning by targeting the viral capsid protein to disrupt multiple stages of the viral life cycle. This category provides a comprehensive selection of reference standards designed to support the rigorous analytical demands of pharmaceutical development and quality control. The collection includes high-quality Lenacapavir Sodium active pharmaceutical ingredients (API), alongside a variety of pharmacopeial and non-pharmacopeial impurities essential for accurate impurity profiling and method validation. Laboratories can also utilize stable isotope labelled compounds as reliable internal standards for precise quantification in complex biological matrices. These materials are critical for analytical chemists and researchers ensuring the safety, efficacy, and regulatory compliance of antiretroviral therapies throughout the drug development lifecycle.